Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (51-60 of 350) with videos related to

Pageof 35
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2019
Global timing of hepatitis C virus elimination in high-income countriesHomie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2020
Response to Taiwan is on track of accelerating hepatitis C elimination by 2025Homie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, et al.
Journal of Gastroenterology and Hepatology|December 11, 2002
Polyethylene glycol-interferon: current status in hepatitis C virus therapyHeiner Wedemeyer, Johannes Wiegand, Markus Cornberg, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2021
Petra Lynen Jansen, Pia van Leeuwen, Lisa Sandmann, et al.
Virology|November 4, 2024
MitoTempo treatment as an approach to cure persistent viral infections?Jasmin Mischke, Sebastian Klein, Markus Cornberg, et al.
Scientific Reports|October 14, 2023
Effects of renin-angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosisTammo L Tergast, Marie Griemsmann, Heiner Wedemeyer, et al.
Journal of Hepatology|March 15, 2021
Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?Lena Stockhoff, Hannah Schneider, Tammo Lambert Tergast, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Whom? When? How? Another piece of evidence for early treatment of acute hepatitis CHeiner Wedemeyer, Elmar Jäckel, Johannes Wiegand, et al.
Gastroenterology|August 8, 2006
Treatment of acute hepatitis C-how to explain the differences?Heiner Wedemeyer, Markus Cornberg, Johannes Wiegand, et al.
Journal of Hepatology|November 16, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference<sup>‡</sup>Markus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Pageof 35

Showing results (51-60 of 350) with videos related to

Sort By:
Pageof 35
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2019
Global timing of hepatitis C virus elimination in high-income countriesHomie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2020
Response to Taiwan is on track of accelerating hepatitis C elimination by 2025Homie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, et al.
Journal of Gastroenterology and Hepatology|December 11, 2002
Polyethylene glycol-interferon: current status in hepatitis C virus therapyHeiner Wedemeyer, Johannes Wiegand, Markus Cornberg, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2021
Petra Lynen Jansen, Pia van Leeuwen, Lisa Sandmann, et al.
Virology|November 4, 2024
MitoTempo treatment as an approach to cure persistent viral infections?Jasmin Mischke, Sebastian Klein, Markus Cornberg, et al.
Scientific Reports|October 14, 2023
Effects of renin-angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosisTammo L Tergast, Marie Griemsmann, Heiner Wedemeyer, et al.
Journal of Hepatology|March 15, 2021
Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?Lena Stockhoff, Hannah Schneider, Tammo Lambert Tergast, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Whom? When? How? Another piece of evidence for early treatment of acute hepatitis CHeiner Wedemeyer, Elmar Jäckel, Johannes Wiegand, et al.
Gastroenterology|August 8, 2006
Treatment of acute hepatitis C-how to explain the differences?Heiner Wedemeyer, Markus Cornberg, Johannes Wiegand, et al.
Journal of Hepatology|November 16, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference<sup>‡</sup>Markus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Pageof 35